Our findings align with a previous report that the cysteine protease inhibitor calpeptin, which mainly inhibits calpain activity, was effective in a mouse model of lung fibrosis induced by intraperitoneal administration of bleomycin [13]. This evidence concerns the gene CTSB and pulmonary fibrosis.